Loading…
Fierce Virtual Series: JPM Week 2021 has ended
avatar for Martin Meeson

Martin Meeson

FUJIFILM Diosynth Biotechnologies
Chief Executive Officer
Martin Meeson is a seasoned executive who brings extensive global experience to the Biotech and Pharmaceutical markets. 

Martin was named Chief Executive Officer on April 1st, 2020 after serving as Chief Operating Officer and President at of our US FDB operations (North Carolina and Texas). Previously Martin served as Chief Financial Officer for the US. Prior to this, Martin worked for the Fujifilm Diosynth organization for over 6 years, holding leadership positions at the United Kingdom site, including Head of Finance and IT. Before joining Fujifilm Diosynth he was Finance Director at Oxford Chemicals where he was responsible for all aspects of Finance, IT, and Purchasing. He has also held leadership positions at Hibernia Foods, ICI/Dupont and KPMG. 

My Speakers Sessions

Tuesday, January 12
 

10:50am EST

3:30pm EST

 
  • Timezone
  • Filter By Date Fierce Virtual Series: JPM Week 2021 Jan 11-13, 2021
  • Filter By Type
  • Interviews
  • Keynote
  • Networking
  • Panel Discussions
  • Presentations